Safety Study of PLX4032 in Patients With Solid Tumors
收藏NIAID Data Ecosystem2026-03-06 收录
官方服务：
资源简介：
The primary objective of this FIH study is to assess the safety and pharmacokinetics of PLX4032 in patients with solid tumors. The secondary objective is to assess the pharmacodynamic activity in paired biopsy specimens obtained from patients with malignant melanoma who have the V600E BRAF oncogenic mutation.
创建时间：
2006-11-15
